130 related articles for article (PubMed ID: 34117654)
21. Treatment-Free Remission in Chronic Myeloid Leukemia.
Bourne G; Bhatia R; Jamy O
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731096
[TBL] [Abstract][Full Text] [Related]
22. Challenges in management of older patients with chronic myeloid leukemia.
Stempel JM; Shallis RM; Wong R; Podoltsev NA
Leuk Lymphoma; 2024 Apr; ():1-14. PubMed ID: 38652861
[TBL] [Abstract][Full Text] [Related]
23. Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia.
Braga AGO; Barbosa Pagnano KB; Campioni MDP; Lopes ABP; Duarte GO; Metze K; Lorand-Metze I
Hematol Transfus Cell Ther; 2024; 46(3):268-272. PubMed ID: 37442648
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations.
Abruzzese E; Mauro M; Apperley J; Chelysheva E
Ther Adv Hematol; 2020; 11():2040620720966120. PubMed ID: 33194164
[TBL] [Abstract][Full Text] [Related]
25. Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia.
Nesr G; Claudiani S; Milojkovic D; Innes A; Fernando F; Caballes I; Mungozi P; Szydlo R; Lovato S; Jayasena C; Apperley J
Leuk Lymphoma; 2024 Apr; ():1-6. PubMed ID: 38652865
[TBL] [Abstract][Full Text] [Related]
26. Successful Pregnancy and Delivery After Frozen-thawed Embryo Transfer Following the Third Discontinuation of Tyrosine Kinase Inhibitor in a Woman with Chronic Myeloid Leukemia.
Takayama K; Fujisawa S; Sakuma T; Hasegawa K; Katsuki K; Akimoto M; Matsumura A; Nakajima Y; Miyazaki T; Murase M; Nakajima H
Intern Med; 2024 Apr; ():. PubMed ID: 38599867
[TBL] [Abstract][Full Text] [Related]
27. Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Flygt H; Söderlund S; Richter J; Saussele S; Koskenvesa P; Stenke L; Mustjoki S; Dimitrijevic A; Stentoft J; Majeed W; Roy L; Wolf D; Dreimane A; Gjertsen BT; Gedde-Dahl T; Ahlstrand E; Markevärn B; Hjorth-Hansen H; Janssen J; Olsson-Strömberg U
Leukemia; 2024 Apr; 38(4):925. PubMed ID: 38418611
[No Abstract] [Full Text] [Related]
28. Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors.
Liu J; Yan S; Du J; Teng L; Yang R; Xu P; Tao W
Heliyon; 2024 Mar; 10(6):e27531. PubMed ID: 38501021
[TBL] [Abstract][Full Text] [Related]
29. Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study.
Pungolino E; D'adda M; De Canal G; Trojani A; Perego A; Elena C; Lunghi F; Turrini M; Borin L; Iurlo A; Latargia ML; Carraro MC; Spina F; Artale S; Anghilieri M; Molteni A; Caramella M; Baruzzo G; Nichelatti M; Di Camillo B; Cairoli R
Eur J Haematol; 2021 Oct; 107(4):436-448. PubMed ID: 34139044
[TBL] [Abstract][Full Text] [Related]
30. Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
Borghi L; Rosti G; Maggi A; Breccia M; Di Bona E; Iurlo A; La Barba G; Sportoletti P; Albano F; Galimberti S; Rivellini F; Cambrin GR; Capodanno I; Cuneo A; Bonifacio M; Sica S; Arcaini L; Capochiani E; Minotto C; Ciceri F; Crugnola M; Di Caprio L; Supekar S; Elena C; Baccarani M; Vegni E
Front Oncol; 2021; 11():638689. PubMed ID: 34123791
[TBL] [Abstract][Full Text] [Related]
31. Unexpected pancytopenia: Dasatinib induced aplastic anemia in chronic myeloid leukemia.
Feld J; Steinberg A; El Jamal SM; Shapira I
J Oncol Pharm Pract; 2022 Jan; 28(1):232-236. PubMed ID: 34152210
[TBL] [Abstract][Full Text] [Related]
32. Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
Shoukier M; Kubiak M; Cortes J
Curr Oncol Rep; 2021 Jun; 23(8):91. PubMed ID: 34125316
[TBL] [Abstract][Full Text] [Related]
33. Metabolic alterations mediated by STAT3 promotes drug persistence in CML.
Patel SB; Nemkov T; Stefanoni D; Benavides GA; Bassal MA; Crown BL; Matkins VR; Camacho V; Kuznetsova V; Hoang AT; Tenen DE; Wolock SL; Park J; Ying L; Yue Z; Chen JY; Yang H; Tenen DG; Ferrell PB; Lu R; Darley-Usmar V; D'Alessandro A; Bhatia R; Welner RS
Leukemia; 2021 Dec; 35(12):3371-3382. PubMed ID: 34120146
[TBL] [Abstract][Full Text] [Related]
34. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia.
Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA
Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580
[TBL] [Abstract][Full Text] [Related]
35. Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia.
Perrone V; Giacomini E; Andretta M; Arenare L; Cillo MR; Latini M; Mecozzi A; Pagliaro R; Vercellone A; Degli Esposti L
Ther Clin Risk Manag; 2021; 17():617-622. PubMed ID: 34135589
[TBL] [Abstract][Full Text] [Related]
36. Asciminib: an investigational agent for the treatment of chronic myeloid leukemia.
Breccia M; Colafigli G; Scalzulli E; Martelli M
Expert Opin Investig Drugs; 2021 Aug; 30(8):803-811. PubMed ID: 34130563
[No Abstract] [Full Text] [Related]
37. Cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors in Taiwan: a nationwide population-based study.
Yang YC; Huang RY; Tsai HJ; Li PC; Yang YH; Hsieh KP
Eur J Prev Cardiol; 2022 Jul; 29(9):1312-1321. PubMed ID: 34179961
[TBL] [Abstract][Full Text] [Related]
38. Oral complaints in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation.
Wysocka-Słowik A; Gil L; Ślebioda Z; Dorocka-Bobkowska B
Med Oral Patol Oral Cir Bucal; 2021 Sep; 26(5):e642-e650. PubMed ID: 34162819
[TBL] [Abstract][Full Text] [Related]
39. A precision medicine classification for treatment of acute myeloid leukemia in older patients.
Mims AS; Kohlschmidt J; Borate U; Blachly JS; Orwick S; Eisfeld AK; Papaioannou D; Nicolet D; Mrόzek K; Stein E; Bhatnagar B; Stone RM; Kolitz JE; Wang ES; Powell BL; Burd A; Levine RL; Druker BJ; Bloomfield CD; Byrd JC
J Hematol Oncol; 2021 Jun; 14(1):96. PubMed ID: 34162404
[TBL] [Abstract][Full Text] [Related]
40. Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells.
Liu Z; Zheng W; Liu Y; Zhou B; Zhang Y; Wang F
Exp Cell Res; 2021 Aug; 405(2):112708. PubMed ID: 34157313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
